#None #Medicare #Xtalks #Maximum Fair Price

Discover Upcoming Webinar on Maximum Fair Price Strategies for IPAY2027

As Medicare's drug negotiation program approaches its second year, a significant shift is taking place in how Maximum Fair Prices (MFPs) are determined. Understanding these changes is crucial for various stakeholders—manufacturers, payers, and policymakers alike. In the upcoming free webinar hosted by Xtalks, experts will delve deep into how the MFP processes are evolving and what implications these will have on the Medicare landscape.

Key Themes of the Webinar

Understanding MFP Evolution

The MFP determination process is critical for assessing drug pricing in a landscape increasingly driven by negotiations. This webinar offers attendees insights on the implications of Year 1 of the MFP program, comparing it with Year 2 to highlight key changes. Stakeholders can expect discussions on pricing methodologies, alignment of expectations among different parties, and the resulting financial implications that come with these MFP changes.

Impacts on Various Stakeholders

One of the integral segments of this discussion will concern who benefits from these established MFP rates. Various stakeholders, including patients, providers, and health plans, will have different experiences and responses to the changes in drug pricing approaches. The panel will specifically explore the ramifications that drug access and market competitiveness will face under these new pricing rules.

Speakers and Their Expertise

The webinar features an esteemed lineup of speakers from Avalere Health. Mike Ciarametaro will moderate the session, bringing his experience as Policy Managing Director. Alongside him will be Neil Lund, Senior Advisor; Milena Sullivan, SVP of Healthcare Policy Practice; and Taylor Schwartz, Evidence Strategy Managing Director. Their collective insights promise to shed light on the complexities of regulatory environments that influence Medicare pricing.

Impact of the Trump Administration

A notable discussion point will be the policies and strategies adopted by the Trump administration regarding MFPs. Attendees will learn how this political backdrop could shape future negotiations and whether we will see a more aggressive push regarding MFP terms in the forthcoming years.

Real-World Observations

Understanding theoretical frameworks is essential, but real-world applications provide the necessary context. The panel will share observations from the industry's current MFP decisions that impact contracting strategies and competitive responses across various therapeutic areas. This real-world perspective will be invaluable for attendees looking to navigate the practical implications of these changes in their own operations.

How to Attend

The live webinar is scheduled for Monday, November 10, 2025, at 11 AM EST (5 PM CET/EU-Central). This is a valuable opportunity for anyone in the healthcare ecosystem to gain insights on how the health sector will adapt to these changes. To register for the event and secure your spot amongst experts and peers, visit the Xtalks webinar page.

About Xtalks

Xtalks serves as a leading platform for hosting educational webinars aimed at the global life sciences, food, healthcare, and medical device communities. Each year, thousands from diverse backgrounds—ranging from pharmaceutical to biotechnology sectors—access quality educational content through Xtalks. The platform not only focuses on the present-day challenges but also provides perspectives on critical trends and innovations that shape the industry's future.

For more information or to register, check out Xtalks’ site at www.xtalks.com. Don't miss out on this enlightening webinar that will equip you with essential tools to navigate the future of drug pricing in the Medicare landscape.